The U.S. International Trade Commission (ITC) voted to institute an investigation of certain microfluidic systems and components—including imports of microfluidic cartridges, reagents, and devices for preparing samples for sequencing.
According to the ITC release, the investigation is based on a complaint filed by a California company in January 2018. In that complaint, it was alleged that there were violations of section 337 of the Tariff Act of 1930 in the importation into the United States and sale of certain microfluidic systems and components thereof and products containing same that infringe the company’s patents. The complainant requests that the USITC issue a limited exclusion order and a cease and desist order.
The launch of an investigation does not mean that the ITC has made a decision on the merits of the case. Instead, the ITC will assign the case to one of its administrative law judges (ALJ), who will schedule and hold an evidentiary hearing. The ALJ will make an initial determination as to whether there is a violation of section 337 and that initial determination will be subject to review by the ITC. A final determination in the investigation will then follow.
For more information, contact a professional with KPMG’s Trade & Customs practice:
Douglas Zuvich | +1 (312) 665-1022 | email@example.com
Andrew Siciliano | +1 (631) 425-6057 | firstname.lastname@example.org
© 2018 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.